Patient : THIRUMALAI N SID No.
: 01011944
Age / Sex : 34 Y / Male Reg Date & Time : 07/03/2020 10:17:13
Referrer : Self Coll Date & Time : 07/03/2020 10:32:34
Branch : VADAPALANI Report Date & Time : 07/03/2020 18:48:52
INVESTIGATION / METHOD RESULT UNITS BIOLOGICAL REFERENCE INTERVAL
HAEMATOLOGY
FULL BODY HEALTH CHECKUP
HAEMOGRAM.
Total WBC Count 5500 cells/cumm 4000-10000
( Method : Optical (Light Scatter))
( Specimen: EDTA WHOLE BLOOD)
DIFFERENTIAL COUNT(DC):EDTA WHOLE BLOOD
(Optical (Light Scatter))
Neutrophils 54 % 45-75
( Specimen: EDTA WHOLE BLOOD)
Lymphocytes 35 % 25-40
( Specimen: EDTA WHOLE BLOOD)
Monocytes 5 % 2-10
( Specimen: EDTA WHOLE BLOOD)
Eosinophils 2 % 1-6
( Specimen: EDTA WHOLE BLOOD)
Basophils 1 % 0-2
( Specimen: EDTA WHOLE BLOOD)
LUC(Large Unstained Cells) 2 % 1-4
( Specimen: EDTA WHOLE BLOOD)
RBC (Red Blood Cell Count) 4.82 Million/cmm 4.5-5.5
( Method : Optical (Light Scatter))
( Specimen: EDTA WHOLE BLOOD)
Haemoglobin 14.3 g/dl 13-17
( Method : Dimethyl laurylamine Oxide)
( Specimen: EDTA WHOLE BLOOD)
PCV -( Haematocrit-Packed Cell Volume) 42.9 % 40-50
( Method : Calculated(Optical))
( Specimen: EDTA WHOLE BLOOD)
MCV (Mean Corpuscular Volume) 89.0 fl 83-101
( Method : Optical (Light Scatter))
( Specimen: EDTA WHOLE BLOOD)
MCH (Mean Corpuscular Hemoglobin ) 29.6 pg 27-32
( Method : Calculated(Optical))
( Specimen: EDTA WHOLE BLOOD)
MCHC (Mean Corpuscular Hemoglobin 33.2 % 31.5-34.5
Concentration)
( Method : Calculated(Optical))
( Specimen: EDTA WHOLE BLOOD)
CH(Mean Hemoglobin Content) 29 24-35
( Specimen: EDTA WHOLE BLOOD)
Page : 1 of 6
Patient : THIRUMALAI N SID No. : 01011944
Age / Sex : 34 Y / Male Reg Date & Time : 07/03/2020 10:17:13
Referrer : Self Coll Date & Time : 07/03/2020 10:32:34
Branch : VADAPALANI Report Date & Time : 07/03/2020 18:48:52
INVESTIGATION / METHOD RESULT UNITS BIOLOGICAL REFERENCE INTERVAL
CHCM(Corpuscular Hemoglobin Concentration 34 29-34
Mean)
( Specimen: EDTA WHOLE BLOOD)
RDW-CV(Red Cell Distribution Width-CV) 13 % 11.6-14.0
( Method : Calculated(Optical))
( Specimen: EDTA WHOLE BLOOD)
HDW(Hemoglobin Distribution Width) 3 1.9-3.0
( Specimen: EDTA WHOLE BLOOD)
Platelet Count 3.54 Lakhs/cumm 1.5-4.1
( Method : Optical (Light Scatter))
( Specimen: EDTA WHOLE BLOOD)
PDW(Platelet Distribution Width) 41 % 8.3 to 56.6
( Specimen: EDTA WHOLE BLOOD)
MPV (Mean Platelet Volume) 9 fl 6.5-12.0
( Specimen: EDTA WHOLE BLOOD)
Large Platelate Count 1 cells/cumm 0-10
( Specimen: EDTA WHOLE BLOOD)
PCT(Plateletcrit) 0.31 % 0.19-0.39
( Specimen: EDTA WHOLE BLOOD)
MPM(Mean Platelet Mass) 1
( Specimen: EDTA WHOLE BLOOD)
MPC(Mean Platelet Concentration) 22
( Specimen: EDTA WHOLE BLOOD)
Absolute Neutrophil Count 2930 cells/cumm 2000 - 7000
( Specimen: EDTA WHOLE BLOOD)
Absolute Lymphocyte Count 1930 cells/cumm 1000-3000
( Specimen: EDTA WHOLE BLOOD)
Absolute Eosinophil Count 130 cells/cumm 20-500
( Method : WB/Automated)
( Specimen: EDTA WHOLE BLOOD)
Absolute Monocytes Count 290 cells/cumm 200-1000
( Specimen: EDTA WHOLE BLOOD)
Absolute Basophils Count 70 cells/cumm 20-100
( Specimen: EDTA WHOLE BLOOD)
ALUC(Absolute Large Unstained Cells) 110 cells/cumm 0-400
( Specimen: EDTA WHOLE BLOOD)
Hypochromia 1 % 0.0-4.0
( Specimen: EDTA WHOLE BLOOD)
Hyperchromia 1 % 0.0-4.0
( Specimen: EDTA WHOLE BLOOD)
Page : 2 of 6
Patient : THIRUMALAI N SID No. : 01011944
Age / Sex : 34 Y / Male Reg Date & Time : 07/03/2020 10:17:13
Referrer : Self Coll Date & Time : 07/03/2020 10:32:34
Branch : VADAPALANI Report Date & Time : 07/03/2020 18:48:52
INVESTIGATION / METHOD RESULT UNITS BIOLOGICAL REFERENCE INTERVAL
Microcytosis 0 % 0.0-5.5
( Specimen: EDTA WHOLE BLOOD)
Macrocytosis 1 % 0.0-5.5
( Specimen: EDTA WHOLE BLOOD)
BIOCHEMISTRY.
FULL BODY HEALTH CHECKUP
GLUCOSE (F) 86.0 mg/dl 74-100
( Method : HEXOKINASE) Pre Diabetes:100-125
( Specimen: FLUORIDE PLASMA) Diabetes :>=126
BIOCHEMISTRY
FULL BODY HEALTH CHECKUP
UREA 19.5 mgs/dl 13-43
( Method : Urease)
( Specimen: SERUM)
Blood Urea Nitrogen(BUN) 9.1 mg/dl 6-20
( Method : Urease/GLDH)
( Specimen: SERUM)
CREATININE 0.8 mg/dl 0.7-1.3
( Method : Creatinine amidohydrolase)
( Specimen: SERUM)
Urea/Creatinine Ratio 24
( Specimen: SERUM)
BUN/Creatinine Ratio 11.4 Ratio 9:1-23:1
( Specimen: SERUM)
URIC ACID 5.9 mg/dl 3.5-7.2
( Method : Uricase)
( Specimen: SERUM)
e-GLOMERULAR FILTRATION RATE (GFR) 117 ml/min/1.73 > = 90 :Normal
( Specimen: SERUM) m2 60-89 :Mild Decrease
45-59 :Mild to moderate Decrease
30-44 :Moderate to severe
Decrease
15-29 :Severe Decrease
CALCIUM 9.1 mg/dl 8.6-10.2
( Method : Arsenazo III)
( Specimen: SERUM)
Page : 3 of 6
Patient : THIRUMALAI N SID No. : 01011944
Age / Sex : 34 Y / Male Reg Date & Time : 07/03/2020 10:17:13
Referrer : Self Coll Date & Time : 07/03/2020 10:32:34
Branch : VADAPALANI Report Date & Time : 07/03/2020 18:48:52
INVESTIGATION / METHOD RESULT UNITS BIOLOGICAL REFERENCE INTERVAL
LIPID PROFILE
CHOLESTEROL 177.0 mgs/dl Desirable :<200
( Method : Cholesterol Oxidase,esterase,Peroxidase) Boderline high :200-239
( Specimen: SERUM) High :>240
HDL CHOLESTEROL 36.0 mgs/dl >40
( Method : Direct)
( Specimen: SERUM)
LDL CHOLESTEROL 123 mgs/dl Optimal :<100
( Method : Direct) Near Optimal/above Optimal:100-
( Specimen: SERUM) 129
Borderline high :132-159
High :159-189
VeryHigh :>190
TRIGLYCERIDES 118.0 mgs/dl Normal :<150 mg/dl
( Method : Lipase/Glycerol Dehydrogenase) Boderline high:150-199 mg/dl
( Specimen: SERUM) High :200-499 mg/dl
very high :>500 mg/dl
VLDL CHOLESTEROL 23.6 mgs/dl 10 - 40
( Method : Calculation)
( Specimen: SERUM)
Non-HDL Cholesterol 141.0 <160 mg/dl
( Specimen: SERUM)
CHO / HDL RATIO 4.9 Ratio Optimal<3.5
( Method : Calculation) Goal <5.0
( Specimen: SERUM)
LDL/HDL RATIO 3.4 Ratio 1.5-3.5
( Specimen: SERUM)
TGL/HDL Ratio 3.3 Ideal :<2.0
( Method : Calculated) High risk :>4.0
( Specimen: SERUM) Very high risk:6.0
LIVER FUNCTION TEST ( without GGT )
BILIRUBIN TOTAL 0.77 mgs/dl 0.3-1.2
( Method : Diazo)
( Specimen: SERUM)
BILIRUBIN DIRECT 0.14 mgs/dl <0.2
( Method : Diazo)
( Specimen: SERUM)
BILIRUBIN INDIRECT 0.63 mgs/dl 0.2 - 0.9
( Method : Diazo)
( Specimen: SERUM)
Page : 4 of 6
Patient : THIRUMALAI N SID No. : 01011944
Age / Sex : 34 Y / Male Reg Date & Time : 07/03/2020 10:17:13
Referrer : Self Coll Date & Time : 07/03/2020 10:32:34
Branch : VADAPALANI Report Date & Time : 07/03/2020 18:48:52
INVESTIGATION / METHOD RESULT UNITS BIOLOGICAL REFERENCE INTERVAL
Serum Glutamic Oxaloacetic 36.0 U/L <35
Transaminase(SGOTorAST)
( Method : IFCC)
( Specimen: SERUM)
Serum Glutamic Pyruvic Transaminase(SGPT or 53.0 U/L <45
ALT)
( Method : IFCC)
( Specimen: SERUM)
ALKALINE PHOSPHATASE 66.0 U/L 53-128
( Method : AMP)
( Specimen: SERUM)
TOTAL PROTEIN 7.70 gms/dl 6.4-8.3
( Method : Biuret)
( Specimen: SERUM)
ALBUMIN 4.70 gms/dl 3.5-5.2
( Specimen: SERUM)
GLOBULIN 3.00 gms/dl 2.3 - 3.5
( Method : Calculation)
( Specimen: SERUM)
A/G RATIO 1.6 0.8-2.0
( Specimen: SERUM)
AST/ALT 0.7
( Method : Calculated)
( Specimen: SERUM)
Page : 5 of 6
Patient : THIRUMALAI N SID No. : 01011944
Age / Sex : 34 Y / Male Reg Date & Time : 07/03/2020 10:17:13
Referrer : Self Coll Date & Time : 07/03/2020 10:32:34
Branch : VADAPALANI Report Date & Time : 07/03/2020 18:48:52
INVESTIGATION / METHOD RESULT UNITS BIOLOGICAL REFERENCE INTERVAL
IMMUNOLOGY
FULL BODY HEALTH CHECKUP
THYROID PROFILE TEST - TOTAL
Total-T3 (Triiodothyronine-T3) 139.0 ng/dl 70-204
( Method : CLIA)
( Specimen: SERUM)
Total-T4 (Thyroxine T4 ) 11.7 ug/dl 4.6-10.5
( Method : CLIA)
( Specimen: SERUM)
TSH (Thyroid-stimulating hormone) 1.53 uIU/ml 0.4-4.5
( Method : CLIA) Pregnancy:
( Specimen: SERUM) 1st Trimester:0.3-4.5
2nd Trimester:0.5-5.6
3rd Trimester:0.8-5.2
VITAMIN B 12 86.00 pg/ml 75-807
( Method : CLIA)
( Specimen: SERUM)
Vit.D Total 25( OH) 12.60 ng/ml Deficiency : < 20
( Method : CLIA) Insufficiency : 20-30
( Specimen: SERUM) Sufficiency : 30-100
Toxicity : > 100
End of the Report
Dr. Mrs. A.VENU ANAND MD.,
Pathologist
Page : 6 of 6